RC
HSTO

RBF Capital’s Histogen Inc. Common Stock HSTO Stock Holding History

RBF Capital’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-65
Closed -$22K – 429
2018
Q4 		$22K Hold
65
– – ﹤0.01% 406
2018
Q3 		$75K Hold
65
– – 0.01% 388
2018
Q2 		$59K Buy
+65
New +$54K 0.01% 382

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RBF Capital's HSTO Position: Q1 2019 in Review

RBF Capital sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 65 shares — an estimated $22K sold.

RBF Capital first reported a position in HSTO in Q2 2018 and held it in 3 quarters. The position peaked at $75K in Q3 2018. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • RBF Capital reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • RBF Capital sold 65 Histogen Inc. Common Stock shares in Q1 2019, an estimated $22K.
  • RBF Capital first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • RBF Capital's Histogen Inc. Common Stock position peaked at $75K in Q3 2018.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on RBF Capital's 13F filing for Q1 2019, filed 15 May 2019.